Boundless Bio Common Stock Market Value
| BOLD Stock | USD 1.26 0.02 1.61% |
| Symbol | Boundless |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Boundless Bio Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio's value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio's market value can be influenced by many factors that don't directly affect Boundless Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Boundless Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boundless Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boundless Bio.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Boundless Bio on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Boundless Bio Common or generate 0.0% return on investment in Boundless Bio over 90 days. Boundless Bio is related to or competes with Q32 Bio, NextCure, Plus Therapeutics, Intensity Therapeutics, Iterum Therapeutics, AN2 Therapeutics, and Pluri. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene ther... More
Boundless Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boundless Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boundless Bio Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (5.11) | |||
| Potential Upside | 4.24 |
Boundless Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boundless Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boundless Bio's standard deviation. In reality, there are many statistical measures that can use Boundless Bio historical prices to predict the future Boundless Bio's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | 0.9042 |
Boundless Bio January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.9142 | |||
| Mean Deviation | 2.29 | |||
| Coefficient Of Variation | (2,131) | |||
| Standard Deviation | 3.13 | |||
| Variance | 9.78 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | 0.9042 | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (5.11) | |||
| Potential Upside | 4.24 | |||
| Skewness | 0.6488 | |||
| Kurtosis | 1.98 |
Boundless Bio Common Backtested Returns
Boundless Bio Common secures Sharpe Ratio (or Efficiency) of -0.079, which signifies that the company had a -0.079 % return per unit of risk over the last 3 months. Boundless Bio Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Boundless Bio's Standard Deviation of 3.13, mean deviation of 2.29, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Boundless Bio are expected to decrease at a much lower rate. During the bear market, Boundless Bio is likely to outperform the market. At this point, Boundless Bio Common has a negative expected return of -0.23%. Please make sure to confirm Boundless Bio's day median price, period momentum indicator, as well as the relationship between the accumulation distribution and potential upside , to decide if Boundless Bio Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.72 |
Almost perfect reverse predictability
Boundless Bio Common has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Boundless Bio time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boundless Bio Common price movement. The serial correlation of -0.72 indicates that around 72.0% of current Boundless Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.72 | |
| Spearman Rank Test | -0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Boundless Bio Common is a strong investment it is important to analyze Boundless Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio's future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports:Check out Boundless Bio Correlation, Boundless Bio Volatility and Boundless Bio Alpha and Beta module to complement your research on Boundless Bio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Boundless Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.